Estradiol / Norethindrone Acetate
Product Images NDC 54868-4677
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Estradiol / Norethindrone Acetate (NDC 54868-4677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Ena 01)
Chemical Structure (Ena 02)
Figure 1a (Ena 03)
Figure 1b (Ena 04)
Figure 2 (Ena 05)
This appears to be a table displaying the number of hot flushes per week for different treatments. The treatments listed are "Placebo", "1 mg Estradiol", and "Estradiol/Norethindrone Acetate Tablets 1.0 mg/0.5 mg". It is unclear what condition or study is being referenced aside from the severity of hot flushes being "moderate-severe".*
Figure 3 (Ena 06)
Figure 4 (Ena 07)
Figure 5 (Ena 08)
Figure 6 (Ena 09)
This is a comparison of the effects of Estradiol and Norethindrone Acetate Tablets in two different groups (U and Us) with different dosages, 1.0 mp/0.5 mg and 1.0 ma/0.5 mg respectively. The change in percentage is being tracked over a lunar month's duration (28 day cycles). No further information can be obtained from this text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.